Harold Davidson & Associates
BMY icon

Harold Davidson & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Harold Davidson & Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$521K Hold
8,350
– – 0.21% 47
2026
Q2 		$481K Sell
8,350
-1,751
-17% -$101K 0.21% 44
2026
Q1 		$613K Sell
10,101
-100
-1% -$5.83K 0.3% 47
2025
Q4 		$550K Sell
10,201
-160
-2% -$7.7K 0.24% 48
2025
Q3 		$467K Buy
10,361
+2,510
+32% +$117K 0.21% 51
2025
Q2 		$363K Sell
7,851
-3,635
-32% -$178K 0.24% 50
2025
Q1 		$701K Sell
11,486
-125
-1% -$7.29K 0.38% 42
2024
Q4 		$657K Buy
+11,611
New +$649K 0.31% 47

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Harold Davidson & Associates's BMY Position: Q3 2026 in Review

Harold Davidson & Associates held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 8,350 shares worth $521K. The position accounts for 0.21% of the portfolio, ranked #47.

Harold Davidson & Associates first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. The position peaked at $701K in Q1 2025. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Harold Davidson & Associates held 8,350 shares of Bristol-Myers Squibb worth $521K as of Q3 2026.
  • Harold Davidson & Associates left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.21% of Harold Davidson & Associates's portfolio in Q3 2026, its #47 holding.
  • Harold Davidson & Associates first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
  • Harold Davidson & Associates's Bristol-Myers Squibb position peaked at $701K in Q1 2025.
  • 1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Harold Davidson & Associates's 13F filing for Q3 2026, filed 29 Oct 2026.